Literature DB >> 9626724

Smooth pursuit and saccadic abnormalities in first-episode schizophrenia.

S B Hutton1, T J Crawford, B K Puri, L J Duncan, M Chapman, C Kennard, T R Barnes, E M Joyce.   

Abstract

BACKGROUND: Previous studies of oculomotor dysfunction in schizophrenia have tended to concentrate on abnormalities of smooth pursuit eye tracking in chronic medicated patients. We report the results of a study of smooth pursuit, reflexive and antisaccade performance in drug naive and antipsychotic treated first-episode schizophrenic patients.
METHODS: Smooth pursuit and saccadic eye movements were recorded in 36 first-episode schizophrenic patients and 36 controls matched for age and estimated IQ. The schizophrenic patients were divided into drug-naive (N = 17) and antipsychotic treated groups (N = 19).
RESULTS: Smooth pursuit velocity gain was significantly lower than controls only in the drug-naive patients. The treated patients did not differ significantly from either the controls or the untreated group. In an antisaccade paradigm both treated and drug-naive schizophrenic patients demonstrated an increased number of errors, but only drug-naive patients also demonstrated an increased latency in initiating correct antisaccades.
CONCLUSIONS: These impairments are unlikely to be due to a generalized deficit in oculomotor function in the schizophrenic groups, as there were no differences between the groups in saccadic metrics on a reflexive saccade task. The results show that both smooth pursuit and saccadic abnormalities are present at the onset of schizophrenia and are integral to the disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626724     DOI: 10.1017/s0033291798006722

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  30 in total

1.  Smooth pursuit and saccadic eye movement performance in a prefrontal leukotomy patient.

Authors:  D C Gooding; W G Iacono; D R Hanson
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

2.  The antisaccade task and neuropsychological tests of prefrontal cortical integrity in schizophrenia: empirical findings and interpretative considerations.

Authors:  Deborah L Levy; Nancy R Mendell; Philip S Holzman
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

3.  Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison.

Authors:  N Rycroft; S B Hutton; O Clowry; C Groomsbridge; A Sierakowski; J M Rusted
Journal:  Psychopharmacology (Berl)       Date:  2007-08-05       Impact factor: 4.530

4.  The relationship of saccadic peak velocity to latency: evidence for a new prosaccadic abnormality in schizophrenia.

Authors:  Rajeev S Ramchandran; Dara S Manoach; Mariya V Cherkasova; Kristen A Lindgren; Donald C Goff; Jason J S Barton
Journal:  Exp Brain Res       Date:  2004-07-29       Impact factor: 1.972

5.  Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression.

Authors:  Saumil S Patel; Joseph Jankovic; Ashley J Hood; Cameron B Jeter; Anne B Sereno
Journal:  J Neurol Sci       Date:  2011-10-21       Impact factor: 3.181

6.  Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study.

Authors:  Shelly L Babin; Ashley J Hood; Adel A Wassef; Nina G Williams; Saumil S Patel; Anne B Sereno
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-06-13       Impact factor: 5.067

Review 7.  Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.

Authors:  Deborah L Levy; Anne B Sereno; Diane C Gooding; Gilllian A O'Driscoll
Journal:  Curr Top Behav Neurosci       Date:  2010

8.  Influence of emotional processing on working memory in schizophrenia.

Authors:  Karla Becerril; Deanna Barch
Journal:  Schizophr Bull       Date:  2010-02-22       Impact factor: 9.306

Review 9.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

10.  Is persistent ketamine use a valid model of the cognitive and oculomotor deficits in schizophrenia?

Authors:  Celia J A Morgan; Vyv Huddy; Michelle Lipton; H Valerie Curran; Eileen M Joyce
Journal:  Biol Psychiatry       Date:  2008-12-25       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.